23oI1V5rQ3LWRyDn99OYSzCgznv7yzHUaZ5sd2Q7Hf8aGoQVCvfgmFo8OPEk
Current position: Home >> Scientific Research >> Paper Publications

Novel trifluoromethyl ketone derivatives as oral cPLA(2)/COX-2 dual inhibitors for resolution of inflammation in rheumatoid arthritis.

Release Time:2025-03-26  Hits:

Journal: Bioorganic chemistry

Volume: 148

Page Number: 107453

ISSN: 0045-2068

Key Words: Acylhydrazone; Inflammation; Oxime ester; Rheumatoid arthritis; Trifluoromethyl ketone

Prev One:The Tumor Microenvironment Mediates the HIF-1α/PD-L1 Pathway to Promote Immune Escape in Colorectal Cancer

Next One:Oxymatrine Attenuates Ulcerative Colitis through Inhibiting Pyroptosis Mediated by the NLRP3 Inflammasome